(TheNewswire)
Mississauga, ON Canada andSacramento, CA USA – TheNewswire - April 17, 2024– Bee Vectoring TechnologiesInternational Inc. (the “Company” or “BVT”) (CSE:BEE) (OTC:BEVVF)(CVE:BEE) is pleased to announce strong spraytrial results for the Company’s proprietary Clonostachys rosea CR-7 (CR-7)biofungicide.
Data from the Michigan State University trial shows that when used ona blueberry crop, BVT’s CR-7 reduced early disease infection (shootstrikes) and Monilinia (mummyberry) fungal disease by over 90% compared to the untreated plot, andwas equally effective as the grower standard (the conventional use ofchemical treatments) when used as a spray application.
“Last year we announced our commercial collaboration and first sales order in thefoliar application market,” said Ashish Malik, CEO of BVT. “Thesestrong results support our work with partner BioSafe Systems and arein line with our plan to expand our addressable market. We arebroadening the use of our proprietary biofungicide to a seedtreatment, a spray application, a soil drench application and more– all in addition to the initial bee vectoring application.”
Dr. Tim Miles, extension specialist and leading expert on blueberrydiseases at Michigan State University, led the 2023 trial on Berkeleyblueberries, a variety highly susceptible to mummy berry. A technicalgrade CR-7 spray was applied to bushes from green tip to petal falland compared to another plot sprayed with the grower standard.
“We can confidently conclude from the Michigan State Universitytrial that BVT’s CR-7 controls fungal disease extremely well as aspray application,” said Dr. Mason Newark, Field Technical Managerat BVT. “This trial demonstrates that CR-7 could be integrated intoa pre-bloom or post-bloom spray program to extend disease controlthroughout the season.”
Mummy berry, caused by the fungus Monilinia vaccinii-corymbosi , is a major blueberry pathogenthat causes yield and quality loss. Primary infections, called shootstrikes, can result in bush dieback and can be a source for secondaryinfections later in the season. Fruit “mummification” is notevident in early stages of development, but as the fruit develops,infected berries turn pink or light brown and eventually shrivel up.These shriveled berries then provide inoculum for subsequent seasons,resulting in a perennial pest pressure if not managed proactively.
There are plans to repeat the trial in coming years. “Additionaltrials will provide useful insights as BVT develops expanded uses ofCR-7 beyond bee vectoring and into more conventional use patterns toexpand control into a full season biological program,” continued Dr.Newark.
About Bee Vectoring Technologies InternationalInc .
BVT, an agriculture technology company, is a marketdisruptor with a significant global market opportunity in the $240billion crop protection and fertilizer market. BVT has pioneered anatural precision agriculture system that replaces chemical pesticidesand wasteful plant protection product sprayapplications by delivering biological pesticide alternatives to cropsusing commercially grown bees. BVT’s award-winning technology,precision vectoring, is completely harmless to bees and allows minuteamounts of naturally-derived pesticides (called biologicals) to bedelivered directly to blooms, providing improved crop protection andyield results than traditional chemical pesticides – and improvingthe health of the soil, the microbiome and the environment. Currently,BVT has over 55 granted patents, many more patents pending in allmajor agricultural countries worldwide and has US EPA registration ofits Vectorite™ with CR-7 (EPA Registration No. 90641-2) for sale asa registered biological fungicide for use on the labeled crops.
Additional information can be viewed at the Company’swebsite www.beevt.com . To receive regular news updates fromthe Company, subscribe at www.beevt.com/newsletter .
BVT Company Contact:
Ashish Malik, President & CEO, BVT
BVT Investor Contacts:
Babak Pedram
Virtus Advisory Group
Tel: 416-646-6779
bpedram@virtusadvisory.com
The CSE has neither approved nordisapproved the contents of this press release. The CSE does notaccept responsibility for the adequacy or accuracy of this release. Certain statements containedin this press release constitute "forward-lookinginformation" as such term is defined in applicable Canadiansecurities legislation. The words "may", "would","could", "should", "potential","will", "seek", "intend","plan", "anticipate", "believe","estimate", "expect" and similar expressions asthey relate to the Company, “annual revenue potential”, areintended to identify forward-looking information. All statements otherthan statements of historical fact may be forward-looking information.Such statements reflect the Company’s current views and intentionswith respect to future events, and current information available tothe Company, and are subject to certain risks, uncertainties andassumptions, including: planted acres, selling price of competitivechemical pesticides and the US to Canadian dollar exchange rate.Material factors or assumptions were applied in providingforward-looking information. Many factors could cause the actualresults, performance or achievements that may be expressed or impliedby such forward-looking information to vary from those describedherein should one or more of these risks or uncertainties materialize.These factors include changes in law, competition, litigation, theability to implement business strategies and pursue businessopportunities, state of the capital markets, the availability of fundsand resources to pursue operations, new technologies, the ability toprotect intellectual property rights, the ability to obtain patentprotection for products, third-party intellectual propertyinfringement claims, regulatory changes affecting products, failingresearch and development activities, the ability to reach and sustainprofitability, dependence on business and technical experts, theability to effectively manage business operations and growth, issuanceof debt, dilution of existing securities, volatility of publiclytraded securities, potential conflicts of interest, unlikelihood ofdividend payments, the potential costs stemming from defendingthird-party intellectual property infringement claims, the ability tosecure relationships with manufacturers and purchasers, as well asgeneral economic, market and business conditions, as well as thoserisk factors discussed or referred to in the Company’s FilingStatement dated August 14,2020, filed with the CSE and securitiesregulatory authorities incertain provinces of Canada and available at www.sedar.com. Should anyfactor affect the Company in an unexpected manner, or shouldassumptions underlying the forward-looking information proveincorrect, the actual results or events may differ materially from theresults or events predicted. Any such forward-looking information isexpressly qualified in its entirety by this cautionary statement.Moreover, the Company does not assume responsibility for the accuracyor completeness of such forward-looking information. Theforward-looking information included in this press release is made asof the date of this press release and the Company undertakes noobligation to publicly update or revise any forward-lookinginformation, other than as required by applicable law. All figures arein Canadian dollars.
Copyright (c) 2024 TheNewswire - All rights reserved.